to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction

NACompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

April 26, 2023

Study Completion Date

September 28, 2023

Conditions
Meibomian Gland DysfunctionDry Eye SyndromesDry Eye
Interventions
DEVICE

Tixel C

Tixel C by Novoxel®, Israel is a thermomechanical system developed for fractional treatment. The system is designed for the treatment of soft tissue by direct conduction of heat, enabling tissue coagulation combined with micro ablation with low thermal damage to the surrounding tissue.

DEVICE

LipiFlow

Thermal pulsation (LipiFlow) consists of the localized application of heat and therapeutic pressure on the four eyelids (upper and lower) with the aim of improving drainage of the Meibomian glands.

Trial Locations (5)

63131

Ophthalmology Associates, St Louis

64154

Moyes Eye Center, Kansas City

78229

PNV Clinical Research, LLC, Texas City

92037

Gordon Schanzlin New Vision Institute, La Jolla

92663

Visionary Research Institute, Newport Beach

All Listed Sponsors
lead

Novoxel Ltd.

INDUSTRY